Dapagliflozin/telmisartan

达格列净/替米沙坦

Report date: 2025/03/17 15:32:57

Base Information

Drug NameDapagliflozin/telmisartan
Drug Alias NameTelmisartan/dapagliflozinTHP001THP-001THP-00101/THP-00102THP-00102/THP-00101
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAngiotensin II Receptor Type 1 antagonistsSodium/glucose cotransporter 2 inhibitors
TargetsAngiotensin II Receptor Type 1Sodium/glucose cotransporter 2
Therapy Area/IndicationsDiabetes Mellitus, Type 2Hypertension
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsYes Telmisartan
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesTHPharm Corp
China Registration ClassN/A

Develop Information

Active CompaniesTHPharm Corp
Inactive CompaniesN/A
Active IndicationsDiabetes Mellitus, Type 2Hypertension
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A